Agilent Technologies (A)
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$150.86+0.59%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · A
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | Oct 2012 | Oct 2011 | Oct 2010 | Oct 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenues | 7,372.0 | 6,948.0 | 6,510.0 | 6,833.0 | 6,848.0 | 6,319.0 | 5,339.0 | 5,163.0 | 4,202.0 | 4,202.0 | 4,202.0 | 4,038.0 | 6,858.0 | 6,858.0 | 6,858.0 | 6,615.0 | 5,774.0 | 5,774.0 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 4,202.0 | 4,202.0 | 4,038.0 | 6,858.0 | 6,858.0 | 6,858.0 | 6,615.0 | 5,774.0 | 5,774.0 |
| Cost of Revenues | 3,404.0 | 3,305.0 | 2,975.0 | 3,368.0 | 3,126.0 | 2,912.0 | 2,502.0 | 2,358.0 | 2,005.0 | 2,005.0 | 2,005.0 | 1,997.0 | 3,254.0 | 3,254.0 | 3,254.0 | 3,086.0 | 2,578.0 | 2,578.0 |
| Operating Expenses & Income | ||||||||||||||||||
| Selling, General & Admin | 1,844.0 | 1,709.0 | 1,568.0 | 1,634.0 | 1,637.0 | 1,619.0 | 1,496.0 | 1,460.0 | 1,253.0 | 1,253.0 | 1,253.0 | 1,189.0 | 1,817.0 | 1,817.0 | 1,817.0 | 1,809.0 | 1,697.0 | 1,697.0 |
| R&D Expenses | 485.0 | 455.0 | 479.0 | 481.0 | 467.0 | 441.0 | 495.0 | 404.0 | 329.0 | 329.0 | 329.0 | 330.0 | 668.0 | 668.0 | 668.0 | 649.0 | 704.0 | 704.0 |
| Operating Income | 1,639.0 | 1,479.0 | 1,488.0 | 1,350.0 | 1,618.0 | 1,347.0 | 846.0 | 941.0 | 615.0 | 615.0 | 615.0 | 522.0 | 1,119.0 | 1,119.0 | 1,119.0 | 1,071.0 | 795.0 | 795.0 |
| Earnings from Continuing Operations | ||||||||||||||||||
| Interest Expense | 106.0 | 112.0 | 96.0 | 95.0 | 84.0 | 81.0 | 78.0 | 74.0 | 72.0 | 72.0 | 72.0 | 66.0 | 101.0 | 101.0 | 101.0 | 86.0 | 123.0 | — |
| Interest & Investment Income | 60.0 | 62.0 | 80.0 | 51.0 | 9.0 | 2.0 | 8.0 | 36.0 | 11.0 | 11.0 | 11.0 | 7.0 | 9.0 | 9.0 | 9.0 | 14.0 | 113.0 | 113.0 |
| Net Interest Expenses | — | — | — | 44.0 | 75.0 | 79.0 | 70.0 | 38.0 | 61.0 | 61.0 | 61.0 | 59.0 | 92.0 | 92.0 | 92.0 | 72.0 | 10.0 | — |
| Asset Writedown | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.0 | 1.0 | — |
| EBT, Incl. Unusual Items | 1,658.0 | 1,435.0 | 1,521.0 | 1,339.0 | 1,504.0 | 1,360.0 | 842.0 | 919.0 | 544.0 | 544.0 | 544.0 | 480.0 | 1,043.0 | 1,043.0 | 1,043.0 | 1,032.0 | 815.0 | 815.0 |
| Income Tax Expense | 218.0 | 132.0 | 232.0 | 99.0 | 250.0 | 150.0 | 123.0 | (152.0) | 82.0 | 82.0 | 82.0 | 42.0 | (110.0) | (110.0) | (110.0) | 20.0 | 122.0 | 122.0 |
| Net Income | ||||||||||||||||||
| Minority Interest | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 7.0 | 3.0 | — |
| Net Income | 1,440.0 | 1,303.0 | 1,289.0 | 1,240.0 | 1,254.0 | 1,210.0 | 719.0 | — | — | — | — | — | — | — | — | — | — | — |
| Per Share | ||||||||||||||||||
| Basic EPS | 5.11 | 4.59 | 4.44 | 4.22 | 4.19 | 3.98 | 2.33 | 3.41 | 1.42 | 1.42 | 1.42 | 1.20 | 3.31 | 3.31 | 3.31 | 2.92 | 1.91 | 1.91 |
| Diluted EPS | 5.09 | 4.57 | 4.43 | 4.19 | 4.18 | 3.94 | 2.30 | 3.37 | 1.40 | 1.40 | 1.40 | 1.20 | 3.27 | 3.27 | 3.27 | 2.85 | 1.87 | 1.87 |
| Revenue per Share | 26.05 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | 0.99 | 0.94 | 0.90 | 0.84 | 0.78 | 0.72 | 0.66 | 0.46 | 0.46 | 0.46 | 0.40 | 0.30 | 0.30 | 0.30 | — | — | — |
| Basic Weighted Avg Shares | 282.0 | 284.0 | 290.0 | 294.0 | 299.0 | 304.0 | 309.0 | 314.0 | 326.0 | 326.0 | 326.0 | 333.0 | 348.0 | 348.0 | 348.0 | 347.0 | 363.0 | 0.0 |
| Diluted Weighted Avg Shares | 283.0 | 285.0 | 291.0 | 296.0 | 300.0 | 307.0 | 312.0 | 318.0 | 329.0 | 329.0 | 329.0 | 335.0 | 353.0 | 353.0 | 353.0 | 355.0 | 371.0 | 0.0 |
| Supplemental | ||||||||||||||||||
| EBITDA | — | 1,767.0 | 1,745.0 | 1,621.0 | 1,935.0 | 1,668.0 | 1,154.0 | 1,179.0 | 861.0 | 861.0 | 861.0 | 775.0 | 1,420.0 | 1,420.0 | 1,420.0 | 1,324.0 | 996.0 | 996.0 |
| EBIT | 1,639.0 | 1,479.0 | 1,488.0 | 1,350.0 | 1,618.0 | 1,347.0 | 846.0 | 941.0 | 615.0 | 615.0 | 615.0 | 522.0 | 1,119.0 | 1,119.0 | 1,119.0 | 1,071.0 | 795.0 | 795.0 |
| Effective Tax Rate | 13.1% | — | — | 7.4% | 16.6% | 11.0% | 14.6% | -16.5% | 15.1% | 15.1% | 15.1% | 8.8% | -10.5% | -10.5% | -10.5% | 1.9% | 15.0% | 15.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.